175 related articles for article (PubMed ID: 23296365)
1. Health-related quality of life in children and adolescents with phenylketonuria: unimpaired HRQoL in patients but feared school failure in parents.
Thimm E; Schmidt LE; Heldt K; Spiekerkoetter U
J Inherit Metab Dis; 2013 Sep; 36(5):767-72. PubMed ID: 23296365
[TBL] [Abstract][Full Text] [Related]
2. Development and psychometric validation of measures to assess the impact of phenylketonuria and its dietary treatment on patients' and parents' quality of life: the phenylketonuria - quality of life (PKU-QOL) questionnaires.
Regnault A; Burlina A; Cunningham A; Bettiol E; Moreau-Stucker F; Benmedjahed K; Bosch AM
Orphanet J Rare Dis; 2015 May; 10():59. PubMed ID: 25958326
[TBL] [Abstract][Full Text] [Related]
3. Quality of life and adherence to treatment in early-treated Brazilian phenylketonuria pediatric patients.
Vieira E; Maia HS; Monteiro CB; Carvalho LM; Tonon T; Vanz AP; Schwartz IVD; Ribeiro MG
Braz J Med Biol Res; 2017 Dec; 51(2):e6709. PubMed ID: 29267500
[TBL] [Abstract][Full Text] [Related]
4. The impact of metabolic control and tetrahydrobiopterin treatment on health related quality of life of patients with early-treated phenylketonuria: A PKU-COBESO study.
Huijbregts SCJ; Bosch AM; Simons QA; Jahja R; Brouwers MCGJ; De Sonneville LMJ; De Vries MC; Hofstede FC; Hollak CEM; Janssen MCH; Langendonk JG; Rubio-Gozalbo ME; Van der Meere JJ; Van der Ploeg AT; Van Spronsen FJ
Mol Genet Metab; 2018 Sep; 125(1-2):96-103. PubMed ID: 30007854
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of quality of life in PKU before and after introducing tetrahydrobiopterin (BH4); a prospective multi-center cohort study.
Demirdas S; Maurice-Stam H; Boelen CC; Hofstede FC; Janssen MC; Langendonk JG; Mulder MF; Rubio-Gozalbo ME; van Spronsen FJ; de Vries M; Grootenhuis MA; Bosch AM
Mol Genet Metab; 2013; 110 Suppl():S49-56. PubMed ID: 24100246
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the impact of phenylketonuria and its treatment on quality of life of patients and parents from seven European countries.
Bosch AM; Burlina A; Cunningham A; Bettiol E; Moreau-Stucker F; Koledova E; Benmedjahed K; Regnault A
Orphanet J Rare Dis; 2015 Jun; 10():80. PubMed ID: 26084935
[TBL] [Abstract][Full Text] [Related]
7. Psychosocial functioning in children with phenylketonuria: Relationships between quality of life and parenting indicators.
Morawska A; Mitchell AE; Etel E; Kirby G; McGill J; Coman D; Inwood A
Child Care Health Dev; 2020 Jan; 46(1):56-65. PubMed ID: 31782540
[TBL] [Abstract][Full Text] [Related]
8. Parenting a child with phenylketonuria or galactosemia: implications for health-related quality of life.
ten Hoedt AE; Maurice-Stam H; Boelen CC; Rubio-Gozalbo ME; van Spronsen FJ; Wijburg FA; Bosch AM; Grootenhuis MA
J Inherit Metab Dis; 2011 Apr; 34(2):391-8. PubMed ID: 21290186
[TBL] [Abstract][Full Text] [Related]
9. The course of life and quality of life of early and continuously treated Dutch patients with phenylketonuria.
Bosch AM; Tybout W; van Spronsen FJ; de Valk HW; Wijburg FA; Grootenhuis MA
J Inherit Metab Dis; 2007 Feb; 30(1):29-34. PubMed ID: 17160615
[TBL] [Abstract][Full Text] [Related]
10. Adherence to clinic recommendations among patients with phenylketonuria in the United States.
Jurecki ER; Cederbaum S; Kopesky J; Perry K; Rohr F; Sanchez-Valle A; Viau KS; Sheinin MY; Cohen-Pfeffer JL
Mol Genet Metab; 2017 Mar; 120(3):190-197. PubMed ID: 28162992
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life in a european sample of adults with early-treated classical PKU.
Maissen-Abgottspon S; Muri R; Hochuli M; Reismann P; Barta AG; Alptekin IM; Hermida-Ameijeiras Á; Burlina AP; Burlina AB; Cazzorla C; Carretta J; Trepp R; Everts R
Orphanet J Rare Dis; 2023 Sep; 18(1):300. PubMed ID: 37740225
[TBL] [Abstract][Full Text] [Related]
12. [Assessment of the life quality in children with phenylketonuria].
Bushueva TV; Vinyarskaya IV; Chernikov VV; Borovik TE; Kuzenkova LM
Vestn Ross Akad Med Nauk; 2014; (11-12):39-45. PubMed ID: 25971125
[TBL] [Abstract][Full Text] [Related]
13. Tetrahydrobiopterin (BH4) in PKU: effect on dietary treatment, metabolic control, and quality of life.
Ziesch B; Weigel J; Thiele A; Mütze U; Rohde C; Ceglarek U; Thiery J; Kiess W; Beblo S
J Inherit Metab Dis; 2012 Nov; 35(6):983-92. PubMed ID: 22391997
[TBL] [Abstract][Full Text] [Related]
14. Sapropterin treatment does not enhance the health-related quality of life of patients with phenylketonuria and their parents.
Feldmann R; Wolfgart E; Weglage J; Rutsch F
Acta Paediatr; 2017 Jun; 106(6):953-959. PubMed ID: 28235150
[TBL] [Abstract][Full Text] [Related]
15. Quality of life and psychologic adjustment in children and adolescents with early treated phenylketonuria can be normal.
Landolt MA; Nuoffer JM; Steinmann B; Superti-Furga A
J Pediatr; 2002 May; 140(5):516-21. PubMed ID: 12032515
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine monitoring in children with early and continuously treated phenylketonuria: results of an international practice survey.
Sharman R; Sullivan KA; Young RM; McGill JJ
J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S417-20. PubMed ID: 20882350
[TBL] [Abstract][Full Text] [Related]
17. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ
Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792
[TBL] [Abstract][Full Text] [Related]
18. Quality of life in children living with PKU - a single-center, cross-sectional, observational study from Hungary.
Becsei D; Hiripi R; Kiss E; Szatmári I; Arató A; Reusz G; Szabó AJ; Bókay J; Zsidegh P
Mol Genet Metab Rep; 2021 Dec; 29():100823. PubMed ID: 34900594
[TBL] [Abstract][Full Text] [Related]
19. Therapy compliance in children with phenylketonuria younger than 5 years: A cohort study.
Walkowiak D; Bukowska-Posadzy A; Kałużny Ł; Ołtarzewski M; Staszewski R; Musielak M; Walkowiak J
Adv Clin Exp Med; 2019 Oct; 28(10):1385-1391. PubMed ID: 31469949
[TBL] [Abstract][Full Text] [Related]
20. Child and parent attributions in chronic pediatric conditions: phenylketonuria (PKU) as an exemplar.
Antshel KM; Brewster S; Waisbren SE
J Child Psychol Psychiatry; 2004 Mar; 45(3):622-30. PubMed ID: 15055380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
